Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

November 30, 2015 7:37 AM ET


Company Overview of Miltenyi Biotec GmbH

Company Overview

Miltenyi Biotec GmbH develops and manufactures cell labeling reagents, cell separation and analysis devices, and systems for clinical applications globally. Its products include MACS sample preparation, MACS cell separation, MACS flow cytometry, MACS cell culture and stimulation, and MACS molecular; research areas include immunology, stem cell research, neuroscience, and cancer research; and clinical applications include clinical development, CliniMACS system, MACS GMP products, CryoMACS freezing products, TheraSorb, graft engineering, immunotherapy, tissue regeneration, and freezing products. The company was founded in 1989 and is based in Bergisch Gladbach, Germany with additional offices ...

Friedrich-Ebert-Straße 68

Bergisch Gladbach,  51429


Founded in 1989


49 2204 8306 2427


49 2204 85197

Key Executives for Miltenyi Biotec GmbH

Chief Executive Officer
Global Head Clinical Products
General Manager of Gangnam District for Seoul
Compensation as of Fiscal Year 2015.

Miltenyi Biotec GmbH Key Developments

TotipotentRX Signs Multi-Year Distribution Agreement with Miltenyi Biotec GmbH for Clinical Product Sales Throughout India

Cesca Therapeutics Inc. announced that its subsidiary, TotipotentRX, has signed a multi-year distribution agreement with Miltenyi Biotec GmbH (Germany) for clinical product sales throughout India. As part of the agreement, TotipotentRX's advanced haploidentical transplant program will incorporate Miltenyi Biotec's CliniMACS® Cell Separation System, used for selecting beneficial cells or depleting donor immune cells from grafts that may interfere with engraftment in preparation for bone marrow transplantation. TotipotentRX provides specialized clinical cell manufacturing technology, services and expertise to major hospital networks in the rapidly growing Indian transplant market, including its exclusive agreement with Fortis Healthcare. With this agreement Miltenyi reinforces Cesca's leadership position while strategically positioning itself for future growth in Asia. Miltenyi Biotec is a global leader and pioneer in delivering comprehensive cell-based reagent/equipment systems to biomedical and clinical researchers. The CliniMACS Cell Separation System is based on proven magnetic cell separation methodology, the renowned MACS® Technology, enabling consistent generation of cellular products for a wide range of clinical applications. Many graft engineering haploidentical transplant protocols employ the use of Miltenyi Biotec products to deplete donor T and B lymphocytes prior to transplantation. Ex-vivo depletion of these cells can greatly reduce the risk of life-threatening Graft versus Host Disease (GVHD), a significant threat to the use of partially matched relatives as donors (haploidentical transplantation) frequently used in India. GVHD occurs when the donor's immune cells attack the recipient's tissue, causing serious damage to major tissues and organs throughout the body.

Similar Private Companies By Industry

Company Name Region
ROVI Cosmetics International GmbH Europe
Glycotope GmbH Europe
DIREVO Industrial Biotechnology GmbH Europe
JeNaCell GmbH Europe
NOXXON Pharma AG Europe

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Miltenyi Biotec GmbH, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at